|
286
|
766
|
8efrA |
Cryoem of the soluble opa1 interfaces with gdp-alfx bound from the helical assembly on a lipid membrane |
|
278
|
766
|
8efsA |
Cryoem of the soluble opa1 tetramer from the apo helical assembly on a lipid membrane |
|
31
|
133
|
7fyfA |
Crystal structure of human fabp4 in complex with 4-(4-fluorophenyl)-2-piperidin-1-yl-3-(1h-tetrazol-5-yl)-7,8-dihydro-5h-pyrano[4,3-b]pyridine |
|
33
|
135
|
7fwlA |
Crystal structure of human fabp4 in complex with 5-[(3,4-dichlorophenyl)methyl]-1,1-dioxo-1,2,5-thiadiazolidin-3-one |
|
29
|
130
|
7fwvA |
Crystal structure of human fabp4 binding site mutated to that of fabp5 in complex with 6-cyclopentyl-n,5-dimethyl-4-phenyl-n-propan-2-yl-3-(1h-tetrazol-5-yl)pyridin-2-amine |
|
31
|
131
|
7fx1A |
Crystal structure of human fabp4 in complex with 2-(3-phenyl-4-piperidin-1-ylphenyl)acetic acid |
|
32
|
134
|
7fwhA |
Crystal structure of human fabp4 in complex with 3-[5-(3,5-dichlorophenyl)tetrazol-2-yl]propanoic acid |
|
31
|
134
|
7fw2A |
Crystal structure of human fabp4 in complex with 5-[(4-chlorophenoxy)methyl]-4-prop-2-enyl-1,2,4-triazole-3-thiol |
|
35
|
134
|
7fw9A |
Crystal structure of human fabp4 in complex with 2-[(3-ethoxycarbonyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)carbamoyl]cyclopentene-1-carboxylic acid |
|
31
|
134
|
7fxgA |
Crystal structure of human fabp4 in complex with 2-chloro-4,6-bis(trifluoromethylsulfanyl)phenol |
|
31
|
134
|
7fxrA |
Crystal structure of human fabp4 in complex with 2-[rac-(9r,10s)-10-benzyl-3,3-dimethyl-1,5-dioxaspiro[5.5]undecan-9-yl]acetic acid |
|
29
|
130
|
7fy9A |
Crystal structure of human fabp4 binding site mutated to that of fabp5 in complex with 2-cyclopentyl-4-(4-fluorophenyl)-6-[1-(methoxymethyl)cyclopentyl]-3-methyl-5-(1h-tetrazol-5-yl)pyridine |
|
33
|
133
|
7fzfA |
Crystal structure of human fabp4 in complex with 2-(6-methyl-4-oxo-5-phenylthieno[2,3-d]pyrimidin-3-yl)butanoic acid |
|
30
|
135
|
7fzaA |
Crystal structure of apo human fabp4, cubic form |
|
33
|
134
|
7fzmA |
Crystal structure of human fabp4 in complex with n-(2,4-dichlorophenyl)-2-(2,6-dihydroxypyrimidin-4-yl)acetamide |
|
32
|
129
|
7fy8A |
Crystal structure of human fabp1 in complex with 2-[[4-cyclopropyl-5-methyl-3-[3-(trifluoromethyl)-1,2,4-oxadiazol-5-yl]thiophen-2-yl]carbamoyl]cyclopentene-1-carboxylic acid |
|
30
|
134
|
7g0vA |
Crystal structure of human fabp4 in complex with rac-(1r,2s)-2-[[3-(trifluoromethyl)phenoxy]methyl]cyclohexane-1-carboxylic acid |
|
30
|
134
|
7g11A |
Crystal structure of human fabp4 in complex with 2,4,6-triisopropylbenzenesulfonic acid |
|
34
|
133
|
7fxeA |
Crystal structure of human fabp4 in complex with 2-(9-benzyl-6-methyl-1,2,3,4-tetrahydrocarbazol-1-yl)acetic acid |
|
30
|
134
|
7fxiA |
Crystal structure of human fabp4 in complex with rac-(1r,3s)-2,2-dimethyl-3-[(2-phenylphenyl)carbamoyl]cyclopropane-1-carboxylic acid |
|
32
|
133
|
7g1yA |
Crystal structure of human fabp4 in complex with 2-[(3-methoxyphenyl)sulfanylmethyl]-1,3-thiazole-4-carboxylic acid |
|
32
|
134
|
7g1rA |
Crystal structure of human fabp4 in complex with 2-[(3-ethoxycarbonylthiophen-2-yl)carbamoyl]cyclopentene-1-carboxylic acid |
|
33
|
133
|
7fxmA |
Crystal structure of human fabp4 in complex with 5-cyclohexyl-2-hydroxybenzoic acid |
|
32
|
134
|
7g1jA |
Crystal structure of human fabp4 in complex with 2-[[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-4,5-dimethylthiophen-2-yl]carbamoyl]cyclohexene-1-carboxylic acid |
|
32
|
134
|
7g1dA |
Crystal structure of human fabp4 in complex with 5-ethyl-6-(3-methoxyphenyl)-3-methyl-2-sulfanylidene-1h-pyrimidin-4-one |
|
30
|
134
|
7g19A |
Crystal structure of human fabp4 in complex with 5-[2-(1h-tetrazol-5-yl)ethyl]-6,7,8,9,10,11-hexahydrocycloocta[b]indole |
|
28
|
130
|
7g13A |
Crystal structure of human fabp4 binding site mutated to that of fabp5 in complex with 4-[[3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]carbamoyl]-3,6-dihydro-2h-pyran-5-carboxylic acid |
|
32
|
134
|
7fzoA |
Crystal structure of human fabp4 in complex with 4-oxo-3-(2-phenylethyl)-10-oxa-3-azatricyclo[5.2.1.01,5]dec-8-ene-6-carboxylic acid |
|
31
|
135
|
7fx4A |
Crystal structure of human fabp4 in complex with rac-(1r,2s)-2-[(3,4-dichlorophenoxy)methyl]cyclohexane-1-carboxylic acid |
|
31
|
134
|
7fyrA |
Crystal structure of human fabp4 in complex with 5-(3,4-dichlorophenyl)-5-methyl-2-sulfanylidene-1,3-diazinane-4,6-dione |
|
34
|
133
|
7fyxA |
Crystal structure of human fabp4 in complex with 2-[(3-phenylthiophen-2-yl)carbamoyl]cyclopentene-1-carboxylic acid |
|
31
|
133
|
7fz9A |
Crystal structure of human fabp4 in complex with n-methyl-6-(3-methylthiophen-2-yl)-4-phenyl-n-propan-2-yl-3-(1h-tetrazol-5-yl)pyridin-2-amine |
|
30
|
134
|
7fzjA |
Crystal structure of human fabp4 in complex with 3-cyclohexyl-2-ethylsulfanyl-6-hydroxypyrimidin-4-one |
|
32
|
133
|
7fy3A |
Crystal structure of human fabp4 in complex with sulfate |
|
31
|
133
|
7fwpA |
Crystal structure of human fabp4 in complex with 3-hydroxy-4-[3-(3-methoxyphenyl)propyl]-2-(2-phenylethyl)-2h-furan-5-one |
|
31
|
130
|
7fy4A |
Crystal structure of human fabp4 binding site mutated to that of fabp5 in complex with 2-benzyl-6-tert-butyl-3-methyl-4-phenyl-5-(1h-tetrazol-5-yl)pyridine |
|
30
|
135
|
7fwjA |
Crystal structure of human fabp4 in complex with 5-cyclohexyl-6-(2,2,2-trifluoroethoxy)-2-(trifluoromethyl)pyridine-3-carboxylic acid |
|
33
|
133
|
7fwbA |
Crystal structure of human fabp4 in complex with 5-[2-(2,4-dichlorophenoxy)phenyl]-1h-tetrazole |
|
28
|
127
|
7g0wA |
Crystal structure of apo human fabp1i monoclinic form ii, twinned with beta=90deg |
|
34
|
133
|
7g1iA |
Crystal structure of human fabp4 in complex with 5-(4-chlorophenyl)-6-(2,2,2-trifluoroethoxy)-2-(trifluoromethyl)pyridine-3-carboxylic acid |
|
31
|
133
|
7g0yA |
Crystal structure of human fabp4 in complex with 2-(2-methoxyanilino)benzoic acid |
|
31
|
134
|
7fxnA |
Crystal structure of human fabp4 in complex with 2-[(2s)-oxolan-2-yl]-4-phenyl-3-(1h-tetrazol-5-yl)-6,7,8,9-tetrahydro-5h-cyclohepta[b]pyridine |
|
29
|
134
|
7g1fA |
Crystal structure of human fabp4 in complex with 1-(4-methylphenyl)sulfonyl-3-(8-tricyclo[5.2.1.02,6]decanyl)urea |
|
31
|
134
|
7fwdA |
Crystal structure of human fabp4 in complex with 3-[1-(4-carbamoylphenyl)-5-(4-fluorophenyl)pyrrol-2-yl]propanoic acid |
|
26
|
130
|
7g15A |
Crystal structure of human fabp4 binding site mutated to that of fabp5 in complex with rac-(1r,2s)-2-[(3,4-dichlorophenoxy)methyl]cyclohexane-1-carboxylic acid |
|
31
|
133
|
7fwgA |
Crystal structure of human fabp4 in complex with 1-[(4-chloro-3-phenoxyphenyl)methyl]-4-hydroxypyridin-2-one |
|
30
|
134
|
7g21A |
Crystal structure of human fabp4 in complex with 4-hydroxy-2-[(e)-2-(2-phenylcyclohexyl)ethenyl]-2,3-dihydropyran-6-one |
|
33
|
133
|
7fy6A |
Crystal structure of human fabp4 in complex with 6-phenyl-11h-pyrimido[4,5-c][2]benzazepin-3-amine |
|
31
|
134
|
7fxhA |
Crystal structure of human fabp4 in complex with 2-[(2r)-oxolan-2-yl]-4-phenyl-3-(1h-tetrazol-5-yl)-6,7,8,9-tetrahydro-5h-cyclohepta[b]pyridine |
|
30
|
133
|
7fz2A |
Crystal structure of human fabp4 in complex with [3-oxo-5-[4-(trifluoromethyl)phenyl]cyclohexen-1-yl] acetate |
